Amikacin sulfate

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

HIV InfectionsMycobacterium Avium-intracellulare InfectionTuberculosis

Phase 2

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

CompletedNCT00000641

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Mycobacterium Avium-intracellulare Infection

End: 1994-12-31Target: 90Updated: 2021-11-03

Unknown Phase

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

CompletedNCT00000796

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Tuberculosis

End: 1998-10-31Target: 525Updated: 2021-11-03